| Literature DB >> 35126552 |
Jacek Kurzawski1, Łukasz Piątek2, Łukasz Zandecki2, Karolina Piątek2, Łukasz Turek2.
Abstract
INTRODUCTION: Arterial cannulation is inherently associated with a risk of vascular complications including pseudoaneurysm (psA) that are encountered in both radial and femoral artery access. Among various methods of treatment of pseudoaneurysm the most popular are: watchful waiting for a spontaneous resolution, ultrasound-guided compression, ultrasound-guided thrombin injection (UGTI) and surgical treatment. In many previous reports nonsurgical methods appeared to be effective in most cases. AIM: To evaluate the incidence, characteristics as well as treatment scheme of iatrogenic pseudoaneurysms in a single high-volume cardiovascular intervention center.Entities:
Keywords: access site; femoral approach; radial approach
Year: 2021 PMID: 35126552 PMCID: PMC8802644 DOI: 10.5114/aic.2021.111039
Source DB: PubMed Journal: Postepy Kardiol Interwencyjnej ISSN: 1734-9338 Impact factor: 1.426
Baseline characteristics of radial artery and femoral artery pseudoaneurysm (psA) cohorts
| Parameter | Radial artery psA | Femoral artery psA | |
|---|---|---|---|
| Age | 75.9 ±7.3 | 67.7 ±12.1 | 0.02 |
| Female sex | 8 (72.7%) | 54 (52.9%) | 0.35 |
| BSA [m2] | 1.7 ±0.1 | 1.9 ±0.2 | 0.06 |
| Comorbidities: | |||
| Hypertension | 10 (90.0%) | 71 (69.6%) | 0.26 |
| Diabetes | 6 (54.5%) | 22 (21.6%) | 0.04 |
| Dyslipidemia | 7 (63.6%) | 64 (62.7%) | 0.79 |
| Heart failure | 3 (27.3%) | 39 (38.2%) | 0.70 |
| Intervention: | 0.02 | ||
| STEMI | 1 (9.1%) | 30 (29.4%) | |
| NSTE-ACS | 6 (54.5%) | 40 (39.2%) | |
| Scheduled CA or PCI | 4 (36.4%) | 8 (7.8%) | |
| Electrophysiology | 0 (0%) | 15 (14.7%) | |
| Other | 0 (0%) | 9 (8.8%) | |
| Sheath size 6 or less | 11 (100%) | 59 (57.8%) | 0.02 |
BSA – body surface area, STEMI – ST-segment elevation myocardial infarction, NSTE-ACS – nonST-segment elevation acute coronary syndrome, CA – coronary angiography, PCI – percutaneous coronary intervention.
Medical treatment of radial artery and femoral artery pseudoaneurysm (psA) cohorts
| Parameter | Radial artery psA | Femoral artery psA | |
|---|---|---|---|
| Medical treatment | |||
| Aspirin | 10 (90.9%) | 89 (87.3%) | 0.89 |
| P2Y12 inhibitor | 6 (54.5%) | 70 (68.6%) | 0.54 |
| Heparin | 3 (27.3%) | 12 (11.8%) | 0.33 |
| VKA | 1 (9.1%) | 6 (5.9%) | 0.81 |
| NOAC | 1 (9.1%) | 7 (6.9%) | 0.73 |
VKA – vitamin K antagonists, NOAC – non-vitamin K oral anticoagulants.
Clinical manifestation and ultrasonographic characteristics of artery and femoral artery pseudoaneurysms (psA)
| Parameter | Radial artery psA | Femoral artery psA | |
|---|---|---|---|
| Clinical manifestation: | |||
| Pain | 9 (81.8%) | 78 (76.5%) | 0.98 |
| Pulsation | 8 (72.7%) | 27 (26.5%) | < 0.01* |
| Bruise | 6 (54.5%) | 56 (54.9%) | 0.77 |
| Hematoma | 6 (54.5%) | 56 (54.9%) | 0.77 |
| PsA characteristics: | |||
| PsA volume | 1.2 ±1.2 | 3.4 (4.2) | 0.04* |
| Number of psA sacs | 2 (1–3) | 1 (1–1) | < 0.01* |
| PsA neck length | 2.1 ±2.1 | 7.3 ±7.6 | 0.04* |
Methods of treatment of radial artery and femoral artery pseudoaneurysms (psA)
| Parameter | Radial artery psA | Femoral artery psA | |
|---|---|---|---|
| Treatment method: | 0.71 | ||
| UGTI | 10 (90.9%) | 96 (94.1%) | |
| Compression | 0 (0%) | 1 (1.0%) | |
| Surgery | 0 (0%) | 2 (2.0%) | |
| Spontaneous embolization | 1 (9.1%) | 3 (2.9%) | |
| Time from cannulation to UGTI [h] | 89 (15–126) | 66 (25–118) | 0.56 |
UGTI – ultrasound-guided thrombin injection.
Figure 1Treatment of the pseudoaneurysm (psA) cases